Harpoon Therapeutics Competitors and Similar CompaniesClear all
Harpoon Therapeutics's competitors and similar companies include Olema Oncology, Odyssey Therapeutics, ImmunoGen and Aeglea.
 Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. | ||
Founding Date | Founding Date 2015 | Founding Date 2007 | Founding Date 2021 | Founding Date 1981 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ Louisville, US South San Francisco, US | Locations San Francisco, US HQ San Francisco, US | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US | Locations Waltham, US HQ | Locations Austin, US HQ |
Employees | Employees 45 | Employees 9630% increase | Employees 1481% decrease | Employees 277161% increase | Employees 65117% increase |
Valuation ($) | Valuation ($) 492.3 m | Valuation ($) 679.2 m | Valuation ($) N/A | Valuation ($) 8.7 b | Valuation ($) 48.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $31.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) N/A |
Net income | Net income ($67.7m) (FY, 2022) | Net income ($162.5m) (FY, 2025) | Net income N/A | Net income ($222.9m) (FY, 2022) | Net income ($155.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 130m | Total funding raised $ 145.1m | Total funding raised $ 386m | Total funding raised $ 56m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View companyImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View companyAeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View company